Jonathan Kochav, MD
Adult Congenital Heart Disease · New York, NYNPI 1700298023
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,063 of the $1,368 with a category attached, or 77.7%. It is spread thinly across 9 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $356 and has fallen 93.2% since, to $24 in 2025.
Across 26 payments — averaging $52.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$273
- Medtronic$250
- Boston Scientific$247
- AstraZeneca$193
- Pfizer$121
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$106
- plus $178 from 3 others
What the payments were for
- Food & beverage$1,06378%
- Education$30522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 4 | $273 |
| Medtronic | 6 | $250 |
| Boston Scientific | 2 | $247 |
| AstraZeneca | 4 | $193 |
| Pfizer | 1 | $121 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $106 |
| Astellas Pharma US Inc | 1 | $99 |
| Novartis | 3 | $64 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HeartMate 3 Left Ventricular Dev$159
- EMBLEM$124
- EMBLEM MRI S-ICD$123
- ELIQUIS$121
How this compares
Too few adult congenital heart disease providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult congenital heart disease in New York
- Robert SommerNew York$82K
- Harsimran SinghNew York$10K
- Noa Zemer WassercugNew York$983
- Yamini KrishnamurthyNew York$871
- Su YuanNew York$602
- Kali HopkinsNew York$494
- Eihab GhantousNew York$358
- Adam SmallNew York$322
- Matthew LewisNew York$69
- Emily SlaterNew York$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.